Curcumin (0–32 μM) as a potential antitumor agent, reduces expression of S100A8 and P-gp in a time- and dose-dependent manner to promote DOX accumulation and induce apoptosis in leukemia cells [138]. The gene discussed is S100A8; the disease is leukemia.